Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

INSPRA

BGP PHARMA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of INSPRA in Canada?

A shortage of INSPRA 25MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 16, 2026), but it has not started yet.

Why is INSPRA not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will INSPRA be available again?

The manufacturer's estimated resolution date is December 29, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file3 products
Expected resolution~2 months remaining (estimate)
Affected strength25MG
Report last updated2026-10-16
Checked by MedShort2026-10-17

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

INSPRA

BGP PHARMA ULC

50MG · DIN 02323060

Different strengthSame dosage formSame routeNo current shortage

MINT-EPLERENONE

MINT PHARMACEUTICALS INC

50MG · DIN 02471450

Different strengthSame dosage formSame routeNo current shortage

JAMP EPLERENONE

JAMP PHARMA CORPORATION

50MG · DIN 02543397

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2026-12-29

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02323052

Strength

25MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

EPLERENONE

Tier

Unrated

Last Updated

2026-10-16

Reason for Shortage

Disruption of the manufacture of the drug.